Kura Oncology (KURA) Cash from Financing Activities (2010 - 2026)
Kura Oncology (KURA) reported Cash from Financing Activities of $1.5 million for Q2 2026, up 191.1% from $515,000 a year earlier.
Powered by 
Analysis
Kura Oncology (KURA) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kura Oncology's Cash from Financing Activities came in at $2.7 million, down 26.3% year-over-year; for FY2025, it was $1.79 million, down 98.8% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of -67.2% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $154.42 million in FY2024 (+62.9%), $94.78 million in FY2023 (+145.8%), $38.57 million in FY2022 and -$3.44 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Cash from Financing Activities since Q3 2024.
- Year over year, Cash from Financing Activities gained in three of the last six quarters, with growth averaging 2.3%.
- The high point for year-over-year Cash from Financing Activities in five years was Q1 2022 (growth of 283.5%); the low point was Q1 2025 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn | 1.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Mn |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 806,000.00 |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 148.37 Mn |
| Dec 31, 2023 | 691,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Dec 31, 2022 | 34.71 Mn |
| Sep 30, 2022 | 880,000.00 |
| Jun 30, 2022 | 2.67 Mn |
| Mar 31, 2022 | 303,000.00 |
| Dec 31, 2021 | 794,000.00 |
| Sep 30, 2021 | 2.26 Mn |
| Jun 30, 2021 | -6.57 Mn |
| Mar 31, 2021 | 79,000.00 |
| Dec 31, 2020 | 327.04 Mn |
API Access
Kura Oncology Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();